EP2922416A4 - MANIPULATED SECRETATED PROTEINS AND METHOD - Google Patents

MANIPULATED SECRETATED PROTEINS AND METHOD

Info

Publication number
EP2922416A4
EP2922416A4 EP13856957.9A EP13856957A EP2922416A4 EP 2922416 A4 EP2922416 A4 EP 2922416A4 EP 13856957 A EP13856957 A EP 13856957A EP 2922416 A4 EP2922416 A4 EP 2922416A4
Authority
EP
European Patent Office
Prior art keywords
methods
secreted proteins
modified secreted
modified
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13856957.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2922416A1 (en
Inventor
Subhayu Basu
Katherine G Gora
Ying-Ja Chen
David M Young
Nathaniel W Silver
Michael Hamill
David A Berry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axcella Health Inc
Original Assignee
Pronutria Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pronutria Inc filed Critical Pronutria Inc
Publication of EP2922416A1 publication Critical patent/EP2922416A1/en
Publication of EP2922416A4 publication Critical patent/EP2922416A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2437—Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
    • C12N9/2445—Beta-glucosidase (3.2.1.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2477—Hemicellulases not provided in a preceding group
    • C12N9/248—Xylanases
    • C12N9/2482—Endo-1,4-beta-xylanase (3.2.1.8)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP13856957.9A 2012-11-20 2013-11-20 MANIPULATED SECRETATED PROTEINS AND METHOD Withdrawn EP2922416A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261728427P 2012-11-20 2012-11-20
PCT/US2013/071091 WO2014081884A1 (en) 2012-11-20 2013-11-20 Engineered secreted proteins and methods

Publications (2)

Publication Number Publication Date
EP2922416A1 EP2922416A1 (en) 2015-09-30
EP2922416A4 true EP2922416A4 (en) 2016-07-20

Family

ID=50776536

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13856957.9A Withdrawn EP2922416A4 (en) 2012-11-20 2013-11-20 MANIPULATED SECRETATED PROTEINS AND METHOD

Country Status (7)

Country Link
US (1) US20150307562A1 (enExample)
EP (1) EP2922416A4 (enExample)
JP (1) JP2016500250A (enExample)
CN (1) CN104936466A (enExample)
CA (1) CA2892021A1 (enExample)
HK (1) HK1214739A1 (enExample)
WO (1) WO2014081884A1 (enExample)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10689681B2 (en) * 2013-05-31 2020-06-23 Dsm Ip Assets B.V. Microorganisms for diterpene production
BR112016002067A2 (pt) 2013-07-29 2017-08-29 Danisco Us Inc Variantes de enzimas
SG11201602012RA (en) * 2013-09-25 2016-04-28 Pronutria Inc Compositions and formulations for maintaining and increasing muscle mass, strength, and performance and methods of production and use thereof
GB201401699D0 (en) * 2014-01-31 2014-03-19 Dupont Nutrition Biosci Aps Protein
CN103881994B (zh) * 2014-04-14 2020-03-27 中国农业科学院生物技术研究所 一种具有高转糖苷活性的β-半乳糖苷酶突变体及其制备方法和应用
FR3022558B1 (fr) 2014-06-20 2019-01-25 Proteus Variants d'exoglucanases a activite amelioree et leurs utilisations
WO2016046234A2 (en) * 2014-09-22 2016-03-31 Nexttobe Ab Recombinant phe-free proteins for use in the treatment of phenylketonuria
WO2016054452A1 (en) * 2014-10-01 2016-04-07 Ansun Biopharma, Inc. Ecotin variants
WO2016077457A1 (en) * 2014-11-11 2016-05-19 Clara Foods Co. Methods and compositions for egg white protein production
MX383142B (es) 2014-12-19 2025-03-13 Novozymes As Composiciones que comprenden polipéptidos que tienen actividad xilanasa y polipéptidos que tienen actividad arabinofuranosidasa.
GB201501565D0 (en) * 2015-01-30 2015-03-18 Dupont Nutrition Biosci Aps Method
US20180243392A1 (en) * 2015-03-17 2018-08-30 Vanderbilt University Cs21 and lnga protein vaccines
AU2016282355B2 (en) * 2015-06-26 2020-04-09 Novozymes A/S Method for producing a coffee extract
US10188135B2 (en) * 2015-11-04 2019-01-29 Stokley-Van Camp, Inc. Method for inducing satiety
JP7072151B2 (ja) * 2016-02-18 2022-05-20 天野エンザイム株式会社 腸内菌叢改善剤
ES3014057T3 (en) * 2016-05-24 2025-04-16 Novozymes As Gastric stable polypeptides having alpha-galactosidase activity and polynucleotides encoding same
AU2017270269A1 (en) * 2016-05-24 2018-11-15 Novozymes A/S Compositions comprising polypeptides having galactanase activity and polypeptides having beta-galactosidase activity
AU2017269498A1 (en) 2016-05-24 2018-11-08 Novozymes A/S Polypeptides having alpha-galactosidase activity and polynucleotides encoding same
WO2018005035A1 (en) 2016-06-27 2018-01-04 Novozymes A/S Method of dewatering post fermentation fluids
RU2752204C2 (ru) * 2016-07-08 2021-07-23 Новозимс А/С Варианты ксиланазы и кодирующие их полинуклеотиды
WO2018016483A1 (ja) * 2016-07-19 2018-01-25 サントリーホールディングス株式会社 モグロールまたはモグロール配糖体の生産方法
MA43352B1 (fr) 2016-09-01 2019-08-30 Metax Inst Fuer Diaetetik Gmbh Protéine sans phénylalanine pour le traitement de la phénylcétonurie
EA201891926A1 (ru) * 2017-02-03 2019-04-30 Киверди, Инк. Микроорганизмы и искусственные экосистемы для производства белка, продуктов питания и полезных побочных продуктов из субстратов c1
CN110505903A (zh) * 2017-03-06 2019-11-26 杜邦营养生物科学有限公司 新型真菌岩藻糖苷酶及其在预防和/或治疗动物病原体感染中的用途
EP3840582A4 (en) * 2018-08-21 2022-08-03 Clara Foods Co. MODIFICATION OF PROTEIN GLYCOSYLATION IN MICROORGANISMS
CA3118924A1 (en) 2018-11-09 2020-05-14 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
AR118444A1 (es) * 2019-03-19 2021-10-06 Bayer Cropscience Lp Proteínas de fusión, bacterias recombinantes y fragmentos de exosporas para la salud de las plantas
FI13395Y1 (fi) 2019-07-11 2023-06-06 Clara Foods Co Koostumuksia, jotka käsittävät rekombinanttia ovomukoidiproteiinia
US12096784B2 (en) 2019-07-11 2024-09-24 Clara Foods Co. Protein compositions and consumable products thereof
US10927360B1 (en) 2019-08-07 2021-02-23 Clara Foods Co. Compositions comprising digestive enzymes
EP4031661A1 (en) 2019-09-16 2022-07-27 Novozymes A/S Polypeptides having beta-glucanase activity and polynucleotides encoding same
EP3892290A1 (en) * 2020-04-08 2021-10-13 NUMAFERM GmbH Variants of hlya and uses thereof
WO2022194375A1 (en) 2020-03-18 2022-09-22 Numaferm Gmbh Fusion proteins comprising gg repeat sequences
WO2021207679A1 (en) * 2020-04-10 2021-10-14 Liberty Biosecurity, Llc Polypeptide compositions and uses thereof
KR20230107636A (ko) * 2020-11-13 2023-07-17 퍼펙트 데이, 인크. 식품 및 기타 제품에 사용하기 위한 재조합 성분을 생성하기 위한 방법 및 조성물
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
CA3210777A1 (en) 2021-02-10 2022-08-18 Novozymes A/S Polypeptides having pectinase activity, polynucleotides encoding same, and uses thereof
EP4314242A4 (en) * 2021-03-25 2025-01-22 Bio-Cat, Inc. MIXTURES OF FUNGAL PROTEASES AND THEIR USES
CN114015678A (zh) * 2021-09-30 2022-02-08 中南民族大学 一种球形赖氨酸芽孢杆菌C3-41来源的氨肽酶Amp0279及其重组菌株和应用
MX2021014268A (es) * 2021-11-19 2022-02-16 Univ Mexico Nac Autonoma Proteina optimizada que comprende los aminoacidos esenciales para la nutricion humana.
US20230281444A1 (en) * 2022-03-04 2023-09-07 Cella Farms Inc Computational system and algorithm for selecting nutritional microorganisms based on in silico protein quality determination
CA3253720A1 (en) 2022-04-20 2023-10-26 Novozymes A/S PROCESS FOR PRODUCING FREE FATTY ACIDS
US20250345378A1 (en) * 2022-05-04 2025-11-13 Locus Biosciences, Inc. Phage compositions for escherichia comprising crispr-cas systems and methods of use thereof
CN115160420B (zh) * 2022-06-24 2023-06-02 西南大学 盔形毕赤酵母scp类分泌蛋白及其应用
WO2024220717A1 (en) * 2023-04-20 2024-10-24 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
WO2025155915A1 (en) * 2024-01-17 2025-07-24 Anagram Therapeutics, Inc. Methods and compositions for treating congenital sucrase-isomaltase deficiency

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999029882A2 (en) * 1997-12-10 1999-06-17 Pioneer Hi-Bred International, Inc. Methods for altering the nutritional value of a plant protein, vegetative storage protein, vsp, by altering the amino acid content of proteins
WO2003025153A2 (en) * 2001-09-17 2003-03-27 Monsanto Technology, Llc Enhanced proteins and methods for their use
WO2011082304A1 (en) * 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
WO2012128260A1 (ja) * 2011-03-24 2012-09-27 旭硝子株式会社 シゾサッカロミセス属酵母の形質転換体、該形質転換体の製造方法、β－グルコシダーゼの製造方法、およびセルロースの分解方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800726B1 (en) * 1996-11-01 2004-10-05 Pioneer Hi-Bred International, Inc. Proteins with increased levels of essential amino acids
US20060159724A1 (en) * 2000-08-08 2006-07-20 Bell Stacey J Nutritional supplement for the management of weight
US7273738B2 (en) * 2002-10-01 2007-09-25 Novozymes A/S Family GH-61 polypeptides
CN1557475A (zh) * 2004-02-04 2004-12-29 高春平 美容、减肥营养组合物
EP2327316B1 (en) * 2009-11-29 2016-11-16 Premier Nutrition Corporation Method of enhancing muscle protein synthesis
EP2831098A4 (en) * 2012-03-26 2016-12-07 Axcella Health Inc LOADED NUTRIENT PROTEINS AND METHODS

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999029882A2 (en) * 1997-12-10 1999-06-17 Pioneer Hi-Bred International, Inc. Methods for altering the nutritional value of a plant protein, vegetative storage protein, vsp, by altering the amino acid content of proteins
WO2003025153A2 (en) * 2001-09-17 2003-03-27 Monsanto Technology, Llc Enhanced proteins and methods for their use
WO2011082304A1 (en) * 2009-12-31 2011-07-07 Pioneer Hi-Bred International, Inc. Engineering plant resistance to diseases caused by pathogens
WO2012128260A1 (ja) * 2011-03-24 2012-09-27 旭硝子株式会社 シゾサッカロミセス属酵母の形質転換体、該形質転換体の製造方法、β－グルコシダーゼの製造方法、およびセルロースの分解方法
EP2703484A1 (en) * 2011-03-24 2014-03-05 Asahi Glass Company, Limited Transformant of yeast of genus schizosaccharomyces, method for producing same, method for producing beta-glucosidase, and method for decomposing cellulose

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CHEN X ET AL: "Site-directed mutagenesis of an Aspergillus niger xylanase B and its expression, purification and enzymatic characterization in Pichia pastoris", PROCESS BIOCHEMISTRY, ELSEVIER, NL, vol. 45, no. 1, 18 August 2009 (2009-08-18), pages 75 - 80, XP026771160, ISSN: 1359-5113, [retrieved on 20090818], DOI: 10.1016/J.PROCBIO.2009.08.009 *
MCGLOUGHLIN ET AL: "Modifying agricultural crops for improved nutrition", NEW BIOTECHNOLOGY, ELSEVIER BV, NL, vol. 27, no. 5, 30 November 2010 (2010-11-30), pages 494 - 504, XP027526407, ISSN: 1871-6784, [retrieved on 20101124] *
OSSI TURUNEN ET AL: "Engineering of multiple arginines into the Ser/Thr surface of Trichoderma reesei endo-1,4-[beta]-xylanase II increases the thermotolerance and shifts the pH optimum towards alkaline pH", PROTEIN ENGINEERING, vol. 15, no. 2, February 2002 (2002-02-01), pages 141 - 145, XP055156294 *
S. UFAZ ET AL: "Improving the Content of Essential Amino Acids in Crop Plants: Goals and Opportunities", PLANT PHYSIOLOGY., vol. 147, no. 3, 8 May 2008 (2008-05-08), US, pages 954 - 961, XP055279433, ISSN: 0032-0889, DOI: 10.1104/pp.108.118091 *
See also references of WO2014081884A1 *
SIERKS M R ET AL: "PROTEIN ENGINEERING OF THE RELATIVE SPECIFICTY OF GLUCOAMYLASE FROMASPERGILLUS AWAMORI BASED ON SEQUENCE SIMILARITIES BETWEEN STARCH- DEGRADING ENZYMES", PROTEIN ENGINEERING, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 7, no. 12, 1994, pages 1479 - 1484, XP002927868, ISSN: 0269-2139 *
STEFAN BAUER ET AL: "Development and application of a suite of polysaccharide-degrading enzymes for analyzing plant cell walls", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, NATIONAL ACADEMY OF SCIENCES, US, vol. 103, no. 30, 25 July 2006 (2006-07-25), pages 11417 - 11422, XP002679731, ISSN: 0027-8424, [retrieved on 20060714], DOI: 10.1073/PNAS.0604632103 *

Also Published As

Publication number Publication date
CN104936466A (zh) 2015-09-23
WO2014081884A1 (en) 2014-05-30
JP2016500250A (ja) 2016-01-12
WO2014081884A9 (en) 2015-05-21
HK1214739A1 (zh) 2016-09-30
EP2922416A1 (en) 2015-09-30
US20150307562A1 (en) 2015-10-29
CA2892021A1 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
IL288203A (en) Meditopes and meditope-binding antibodies and uses thereof
IL269045A (en) Aptamers and uses thereof
EP2831100A4 (en) NUTRIENT PROTEINS AND METHOD
EP2831098A4 (en) LOADED NUTRIENT PROTEINS AND METHODS
DK2914291T3 (da) Anti-komplement-c1s-antistoffer og anvendelser deraf
PT3199552T (pt) Anticorpos anti-ceacam5 e suas utilizações
BR112014012137A2 (pt) anticorpos anti-fgfr2 e suas utilizações
BR112015001211A2 (pt) novos ácidos 5-aminotetra-hidroquinolina-2-carboxílicos e sua utilização
BR112015003838A2 (pt) formulações de anticorpo e proteína
EP2968551A4 (en) FUSION PROTEINS AND METHOD THEREFOR
EP2877854A4 (en) FUSION PROTEINS AND METHOD THEREFOR
CO7020851A2 (es) Proteínas y péptidos modificados
EP2885418A4 (en) MICROCAPSE COMPOSITIONS AND METHOD THEREFOR
DK2850202T3 (da) Fremgangsmåder og grupper
EP2838954A4 (en) LIABILITY COMPOSITIONS AND METHODS
IL231777A0 (en) Antibodies against tl1a and uses thereof
IL236874A0 (en) Anti-kit antibodies and uses thereof
IL232247B (en) Polypeptide constructs and uses thereof
HRP20182098T1 (hr) Anti-angptl3 antitijela i njihove primjene
IL238227A0 (en) Anti-c16orf54 antibodies and methods of use thereof
EP2934585A4 (en) ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS
HRP20181457T1 (hr) Anti-htra1 protutijela i postupci uporabe
DK3453723T3 (da) Anti-ASIC1-antistoffer og anvendelser deraf
BR112014031384A2 (pt) métodos e sistemas
EP2884984A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150618

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20160620

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 33/17 20160101ALI20160614BHEP

Ipc: C07K 14/38 20060101ALI20160614BHEP

Ipc: A23L 33/00 20160101ALI20160614BHEP

Ipc: C07K 14/32 20060101AFI20160614BHEP

Ipc: A61K 38/16 20060101ALI20160614BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: AXCELLA HEALTH INC.

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1214739

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20170306

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20170919

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 33/00 20160101ALI20160614BHEP

Ipc: C07K 14/38 20060101ALI20160614BHEP

Ipc: A23L 33/17 20160101ALI20160614BHEP

Ipc: C07K 14/32 20060101AFI20160614BHEP

Ipc: A61K 38/16 20060101ALI20160614BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 14/32 20060101AFI20160614BHEP

Ipc: C07K 14/38 20060101ALI20160614BHEP

Ipc: A23L 33/00 20160101ALI20160614BHEP

Ipc: A61K 38/16 20060101ALI20160614BHEP

Ipc: A23L 33/17 20160101ALI20160614BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1214739

Country of ref document: HK